In particular, HER2-enriched breast cancer and TNBC have been reported to show significantly higher TIL density than HR+/HER2− breast cancer, and TILs have been proven to predict the therapeutic effect of chemotherapy [13, 29–31]. The gene discussed is ERBB2; the disease is breast carcinoma.